Press Releases
Novadiscovery raises series A financing to scale its in silico clinical trial platform – Debiopharm leads the round with EUR…
Kaiku Health raises €4.4 million series A financing to accelerate its digital therapeutics pipeline led by Debiopharm and Tesi
BC Platforms Closes USD $10 million Series B Financing led by Debiopharm and Tesi to accelerate knowledge platform development
Debiopharm Innovation Fund: the New Name and Investment Strategy of Debiopharm Diagnostics
Debiopharm Strategic Fund announces FDA clearance of Portfolio Company Immunexpress’ first Test
Debiopharm invests double digit millions in the Canadian startup GenePOC, specialized in the development of rapid diagnostic tests
Debiopharm Diagnostics leads investment round in GenePOC with Emerillon Capital
Debiopharm Diagnostics portfolio company Biocartis ships its first Idylla instrument